Self-Management Interventions for Chronic Pain Relief With Cancer Survivors
CompletedNot applicableNCT03867760
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Cancer survivors who suffer from chronic pain would benefit from a low-cost, self-management intervention they can use at home. This study will evaluate the efficacy of a recorded hypnosis intervention in reducing chronic pain among cancer survivors and will explore its biological and psychological mechanisms.
Study details
- Official title
- Efficacy and Mechanistic Testing of a Self-Management Intervention for Managing Chronic Pain With Cancer Survivors
- Conditions
- Interventions
- Behavioral: Recorded Hypnosis Intervention
- Behavioral: Recorded Relaxation Intervention
- Sponsor
- University of Washington
- Collaborators
- National Institute of Nursing Research (NINR)
- Start date
- 2019-02-21
- Primary completion
- 2021-08-31
- Sex
- All
- Age range
- from 18 Years to 90 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * self-reporting moderate or higher pain on average during the last week (\> 3 on a 0-10 pain intensity numeric scale) * self-reporting experiencing pain at least half of the days in the past 4 weeks * self-reporting chronic pain related to cancer or its treatment * completed active cancer treatment other than maintenance therapy * being \> 18 years of age * functional fluency in English * mentally and physically able to participate and complete surveys Exclusion Criteria: • has a psychiatric condition or symptoms (i.e., diagnosis of paranoid schizophrenia or active paranoid delusional thoughts, as determined via a telephone or in-person screening assessment) that would interfere with study participation. Exclusion Criteria for Optional EEG Measurement: * a history of seizure condition within the last year * a significant brain injury or skull defect * a history of brain cancer.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03867760